期刊文献+

小细胞肺癌住院病例生存情况与预后影响因素分析 被引量:5

Analysis on survival status of inpatients with small cell lung cancer and influencing factors of prognosis
原文传递
导出
摘要 目的对湖南省某三甲医院小细胞肺癌住院病例临床资料进行生存分析,筛选出可能影响小细胞肺癌患者预后的影响因素,为临床治疗与防控提供重要的科学数据。方法收集湖南省某三甲医院2001-2005年小细胞肺癌住院病例的临床资料。采用SPSS19.0进行数据分析,利用寿命表(life table)法和Kaplan-Meier法估计生存率(survival rate)和中位生存时间(median survival time,MST),并绘制生存函数曲线;用对数秩和检验(Log-rank)法分析各组因素反映在生存时间上的差异是否具有统计学意义;最后利用Cox比例风险模型筛选出影响小细胞肺癌住院病例预后的主要影响因素。结果随访2001年1月-2005年12月在湖南省某三甲医院住院治疗的341例小细胞肺癌病例,随访截止时间为2010年12月31日。随访结局生存40例,中途失访2例,完全失访3例,死亡296例。随访应答率为98.53%,数据删失比例为12.9%。全组患者MST为19.65个月,1年、2年、3年和5年生存率分别为67%、40%、32%和16%。单因素分析显示性别、吸烟、喝酒、症状出现至首次治疗开始时间间隔、体重下降、临床分期、是否手术、是否联合治疗、首治疗效等对小细胞肺癌患者预后影响差异有统计学意义(P<0.05)。Cox比例风险模型分析显示性别、吸烟、疾病临床分期、是否联合治疗是小细胞肺癌住院病例预后的主要影响因素。结论性别、吸烟、临床分期、是否联合治疗是影响小细胞肺癌预后的主要影响因素。湖南省某三甲医院2001-2005年小细胞肺癌住院病例生存率与同期国内外文献报道比较,已经达到或略超过同级医院水平。 Objective A survival analysis was conducted on inpatients with small cell lung cancer (SCLC) hospitalized in a 3A -grade hospital in Hunan Province to explore the factors that might affect the prognosis of SCLC,and to provide important scientific references for clinical treatment,prevention and control of SCLC.Methods The clinical data of inpatients diagnoscd with SCLC from a 3A-grade hospital in Hunan Province during 2001 and 2005 were collected and statistically analyzed by SPSS19.0 software.Life-table method and Kaplan-Meier analysis were used to estimate the survival rate and median survival time(MST).The survival function curve was drawed.Log-rank test was used to analyze whether there existed statistical differences in survival period among different groups.COX proportional hazards model was used for screening the main influencing factors of the prognosis of the inpatients with SCLC.Results In total,341 inpatients with SCLC treated in the hospital from January 2001 to December 2005 were followed up.To the end of the follow-up,December 31,2010,40 of them still survived,and 2 cases failed to be followed-up midway,and 3 cases completely failed to be followed up and 296 died of SCLC.The follow -up response rate was 98.53%.The data deletion and loss rate was 12.9%.The MST of all the patients was 19.65 months.The 1-year,2-year,3-year and 5-year survival rates were 67%,40%,32% and 16% respectively.Univariate analysis indicated that gender,smoking,drinking alcohol,the interval between first appearance of symptoms and the first treatment initiation,weight loss,clinical stage,operation,combined therapy and efficacy of the first treatment were factors significantly influencing the prognosis of the inpatients with SCLC (P 〈 0.05).And the COX-proportional hazards model analysis suggested that gender,smoking,clinical stage and combined therapy were main influenciong factors (P 〈 0.05).Conclusions Gender,smoking,clinical stage and combined therapy are the main influencing factors affecting the prognosis of the patients with SCLC.The survival rates of the inpatients with SCLC in the 3A-grade hospital in Hunan Province from January 2001 to December 2005 reach,or slightly surpass those in other 3A-level hospitals both in China and overseas during the same period.
出处 《实用预防医学》 CAS 2014年第4期398-402,共5页 Practical Preventive Medicine
基金 湖南省教育厅重点资助项目(项目编号:11A068)
关键词 小细胞肺癌 生存期 预后分析 Small cell lung cancer (SCLC) Survival time Prognosis analysis
  • 相关文献

参考文献20

  • 1李立明.流行病学[M].北京:人民卫生出版社,2007.454.
  • 2Jernal A, Siegel R, Ward E, et al. Cancer statistics, 2008[J]. CA Cancer J Clin, 2008,58:71 - 96.
  • 3Elias AD. Small cell lung cancer: state of- the- art therapy in 1996 [J]. Chest, 1997,112:2515 -2585.
  • 4World Health Organization. WHO handbook for reporting results of can cer treatment (WHO Offdet Publication No. 48 ) [ R ]. Geneva, Switzerland: World Health Organization, 1979.
  • 5International Agency for Research on Cancer. IARC Biennial Report 2000/2001[M]. Lyou: IACR,2001 : 13 - 14.
  • 6Govindan R, Page N, Morgensztem D, et al. Changing epidemiology of small cell lung cancer in the United States over the last 30 years: anal- ysis of the surveillance, epidemioiogic, and end results database[J ]. J Clin Oncol, 2006,24:4s39 - 44.
  • 7Wheatley - Price P, Ma C, Ashcroft LF, et al. The strength of female sex as a prognostic factor in small cell lung cancer: a pooled analysis of che- mothe rapy trials from the Manchester Lung Group and Medical Re- search Council Clinical Trials Unit[J ]. Ann Oncol, 2010,21 (2):232 - 237.
  • 8李建华,周宝森.小细胞肺癌的预后因素分析[J].中国公共卫生,1998,14(1):14-15. 被引量:5
  • 9Zhang Q, Tang X, Zhang ZF, et al. Nicotine induce hypoxia induc- ible factor - lalpha expression in human lung cancer cells via nicotinic acetyl - choline receptor mediated signaling pathways [J]. Clin Cancer Res, 2007,13 (16) : 4686 - 4694.
  • 10张丽(综述),蔡莉(审校).广泛期小细胞肺癌治疗及预后因素研究进展[J].实用肿瘤学杂志,2010,24(6):586-589. 被引量:2

二级参考文献64

  • 1宋丽华,宋现让,刘美芹,张锡芹,郑莉,李秀菊,刘蒲香.Ⅲ期Ⅳ期非小细胞肺癌预后影响因素分析[J].中华肿瘤杂志,2004,26(6):345-348. 被引量:17
  • 2董海鹰,陈公琰,李晓莉.拓扑替康联合顺铂治疗复发小细胞肺癌的临床观察[J].实用肿瘤学杂志,2005,19(6):442-443. 被引量:1
  • 3李勇,张湘茹,孙燕.小细胞肺癌患者预后的多因素分析[J].中国肺癌杂志,2006,9(6):525-529. 被引量:19
  • 4于世英主译.癌症化疗手册[M].北京:科学出版社,2005:261-278.
  • 5Murray N,CoyP,Pater JL,et al.Importance of timing for thoracic irradiation in the combined modality treatment of limited-stnge smallcell lung cancer.The National Cancer Institute of Canada Clinical Trials Group[J].J Clin Oncol,1993,11 (2):336-344.
  • 6Inoue M,Miyoshl S,Yasumitsu T,et al.Surgical results for small cell lung cancer baaed on the new TNM staging system.Thoracic Surgery Study Group of Osake University,Osaka,Japan[J].Ann Thorac Surg,2000,70(5):1615-1619.
  • 7Shepherd FA,Ginsberg RJ,Feld R,et al.Surgical treatment for limited small cell lung cancer:the University of Toronto Lung Oncolngy Group experience[J].J Thorac Cardiovasc Surq,1991,101 (3):385-393.
  • 8Noda K,Nishiwaki Y,Kawahara M,et al.Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer[J].N Engl J Med,2002,346(2):85-91.
  • 9Socinski M,Weissman C,Hart L,et al.Randomized phase II trial of pemetrexed combined with either cisplatin or arboplatin in untreated extensive-stage small-lung cancer[J].Proc Am Soc Clin Oncol,2006,24(30):4840-4847.
  • 10Slotman B,Faivre-Finn C,Kramer G,et al.Prophylactic cranial irradiation in extensive small-cell lung cancer[J].N Engl J Med,2007,357(7):664-672.

共引文献103

同被引文献47

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部